LAE-102

• Description:

  LAE-102, a monoclonal antibody, is an activin receptor type II-A (ACTRIIA/ACVR2) antagonist. LAE-102 is promising for research of endocrine and metabolic diseases, tumors, and respiratory system diseases[1].

• UNSPSC:

  12352203

• Target:

  Anaplastic lymphoma kinase (ALK) ; TGF-beta/Smad; TGF-β Receptor

• Related Pathways:

  Protein Tyrosine Kinase/RTK; Stem Cell/Wnt; TGF-beta/Smad

• Applications:

  Metabolism-protein/nucleotide metabolism

• Field of Research:

  Cancer; Endocrinology; Metabolic Disease

• Purity:

  99.46

• Smiles:

  [LAE-102]

• Molecular Weight:

  (144.92 kDa)

• References & Citations:

  [1]https://synapse.zhihuiya.com/drug/900ddb627c6a4b1a88d3f4ef37e15c1c

• Shipping Conditions:

  Dry Ice

• Storage Conditions:

  Store at -80°C for 2 years

• Scientific Category:

  Inhibitory Antibodies

• Clinical Information:

  Phase 1